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The enantiomers of the antimuscarinic agent 1-cyclohexyl-1-
(4-fluorophenyl)-4-piperidino-1-butanol [(R)- and (S)-p-fluoro-
hexahydro-difenidol] ((R)- and (S)-2a] and their methiodides (R)-
3 and (S)-3 were prepared with high enantiomeric purity. (R)-
2a and (S)-2a (isolated as hydrochlorides) were obtained by 
catalytic hydrogenation (Pd/C contact) of the corresponding 
enantiomers of 1-cyclohexyl-1-( 4-fl uorophen yl)-4-piperidino-
2-butyn-1-ol [(R)- and (S)-4]. Reaction of (R)-2a and (S)-2a with 
rnethyl iodide led to (R)-3 and (S)-3, respectively. The unsat-
urated precursors (R)- and (S}-4 (enantiorneric purity ~ 99.80 
and ~99.94% e.e.; calorimetric analysis) were prepared by res-
The racemic silanals hexahydro-sila-difenidol (rac-1 b) 
and p-fluoro-hexahydro-sila-difenidol (rac-2 b), both devel-
oped in our laboratories, are commercially available anti-
muscarinic agents that are used as tools in experimental 
pharmacology and physiology for the classification of mus-
carinic receptor subtypes 1•2>. The racemic carbon analogs 
hexahydro-difenidol (rac-1 a) and p-fluoro-hexahydro-difen-
idol (rac-2a) are also potent and selective musearlnie antag-
onists but were found to be somewhat less selective in func-
tional studies than the silicon compounds rac-1 b and rac-
2 b2a.2bl. Because of its receptor selectivity and stereoselective 
antimuscarinic activity, (R)-hexahydro-difenidol [(R)-1 a] 
also proved to be a valuable tool in muscarinic receptor 
research 2c.3>. We were therefore interested in the antimus-
carinic properties of the enantiomers of the p-fluoro deriv-
ative 2a. In this paper we report on the synthesis and prop-
erties of the pure enantiomers of p-fluoro-hexahydro-difen-
idol [(R)-la and (S}-2a] and their methiodides (R)-3 and 
(S)-3. 
The enantiomers of p-fluoro-hexahydro-difenidol (2a) 
were prepared from the unsaturated precursor rac-4 which 
was synthesized by reaction of cyclohexyl 4-fluorophenyl 
ketone with 3-piperidino-1-propyn-1-yl-lithium, followed by 
an aqueous workup. Then the enantiomers of 4 were sepa-
olution of rac-4 [available from 4-FCsH4C(O)C6H11 by reaction 
with LiC ~ CCH2NC5H 10} using (R)- and (S)-mandelic acid as 
resolving agents. The absolute configurations of the (R) and 
(S) enantiomers of 2a, 3, and 4 were determined by an X-ray 
crystal-structure analysis of (S)-5, the methiodide of (S)-4. (R)-
2a and (R)-3 exhibit a higher affinity for muscarinic Mt, M2, 
M3, and M4 receptors (by up to two orders of magnitude) than 
their corresponding antipodes (S)-2a and (S)-3, the degree of 
stereoselectivity depending on the receptor subtype involved. 
(R)-2a represents a useful tool for rnuscarinic receptor research 
(affinity profile: M1 ~ M3 ~ M4 > M2). 
1a 1b 2a 2b 
EI c Si c Si 
R H H F F 
3 
rated by fractional crystallization of their corresponding 
diastereomeric mandelates (for details see Experimental). 
(R)-4 and (S)-4 were obtained as crystalline compounds with 
high enantiomeric purity (see below). Their catalytic hydro-
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genation (Pd/C contact) yielded the enantiomers (R)-2a and 
(S)-2a which were isolated as hydrochlorides [(R)-2a · HCI 
and (S)-2a · HCl]. The methiodides (R)-3 and (S)-3 were 
prepared by quaternization of the corresponding free bases 
(R)-2a and (S)-2a with methyl iodide. 
F~ ~ 
() 
{R)-4 
1 ) H2 [Pd/C] 
2) HCI 
(R)-2a · HCI 
(R)-3 
C=O 
1 ) UC::::CCH2NCsH1o 
2) H20 
rac-4 
resolution with (R)- ond 
{S)-mondelic ocid 
(5)-4 
1 ) H2 [Pd/Cl 
2) HCI 
(S)-2a · HCI 
(S)-3 
The enantiomeric purity of the optically active precursors 
(R)-4 and (S)-4 was determined by differential scanning cal-
orimetry. For the purity determination a newly developed 
procedure 41 was used, which - in contrast to the "classical 
methods" - takes into account both calorimeter and sub-
stance properties and is thus capable of giving more accurate 
results (for details sec Experimental). The data obtained 
from this calorimetric analysis are listed in Table 1, the 
phasediagram ofthe system (R)-4/(S)-4 is shown in Figure 1. 
According to these data, the enantiomeric purity of (R)-4 
and (S)-4 is ~99.80 and ~99.94% e.e., respectively. As the 
catalytic hydrogenation of (R)-4 and (S)-4 and the subse-
quent reactions do not affect the enantiomeric purity (no 
reaction at the center of chirality), the same enantiomeric 
purities can be assumed for (R)-2a · HCl and (R)-3 (~99.8% 
e.e.) as weil as for (S)-2a · HCl and (S)-3 (;;;:99.9% e.e.). 
Table 1. Data for rac-4, (R)-4, and (S)-4 determined by calorimetry 81 
Compound Srus[°C] ll.rusH
9 
[kJmol- 1] X(mol-%] 
rac-4 135.9 46.4 
(R)-4 150.1 46.2 99.90 
(S)-4 150.2 46.2 99.97 
aJ Srus: melting temp.; ll.rusH9 : molar enthalpy of fusion of the race-
mate and the main component, respectively; X: molar fraction of 
the main component. 
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Figure 1. Phase diagram of the system (R)-4/(S)-4 
The absolute configuration of the enantiomers of 2a, 3, 
and 4 was determined by an X-ray crystal-structure analysis 
of the laevorotatory methiodide 5, which was prepared by 
quaternization of (- )-4 with methyl iodide (the signs of the 
optical rotations correspond to solutions of these com-
pounds in CHCh). 
(S)-4 
[
F'O_ /OH 
C CH3 ('( ~. ~~o V ·~c=c-cH2-N 
(S)-5 
e I 
The structure of (- )-5 is depicted in Figure 2. Bond 
lengths and angles (Table 2) are mostly normal, except for 
some librationally shortened bond lengths at the extremes 
of the rings; the precision of Iight-atom dimensions in the 
presence of iodine is necessarily limited. The iodide ion 
forms a hydrogen bond to the hydroxy group [0 ···I 352, 
H···l 267 pm; 0-H···I 172° (I at! + x,!- y, 1 - z). 
As can be seen from Figure 2, (- )-5 has (S) configuration. 
Based on this result, the absolute configuration of the en-
antiomers of 2a, 3, and 4 can also be assigned. 
Both functional and receptor binding sturlies on musca-
rinic Mt-M4 receptors revealed that (R)-p-fluoro-hexa-
hydro-difenidol [(R)-2a] wasmorepotent than its antipode 
(S)-2a by up to two orders of magnitude 2c,Jdl_ The stereo-
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Figure 2. The structure of (S)-5 in the crystal, showing the atom 
numbering scheme; radii are arbitrary; the hydrogen bond is shown 
as a dotted line 
Table 2. Selected bond lengths [pm] and angles [ 0 ] for (S)-5 
F-C(l4) 
N-C(4) 
N-C(32) 
C(l)-C(2) 
C(l) -C(21) 
C(3)-C(4) 
135.8 (4) 
150.8 (4) 
150.8 (5) 
148.5 (4) 
154.5 (4) 
145.9 (4) 
C(4) -N-C(5) 
C(5) -N-C(32) 
C(5) -N-C(36) 
0-C(l) -C(2) 
C(2) -C(l) -C(ll) 
C(2) -C(l) -C(21) 
C(1) -C(2) -C(3) 
N-C(4)-C(3) 
C(1) ·C(ll) -C(16) 
F-C(14) -C(15) 
C(1) -C(21) -C(26) 
N·C(36)-C(35) 
105.9(2) 
111.1(3) 
110.4(2) 
110.1(2) 
109.9(2) 
109.6(3) 
176.5(3) 
114. 7(2) 
123.4(3) 
118.7(3) 
113.0(3) 
112.3(3) 
O·C(1) 
N-C(S) 
N-C(36) 
C(1)-C(11) 
C(2) -C(3) 
143.2 (4) 
149.8 (4) 
151.4 (4) 
152.3 (4) 
118.2 (4) 
C(4)-N-C(32) 
C(4)-N-C(36) 
C(32) -N-C(36) 
O-C(1) -C(ll) 
O-C(1) -C(21) 
C(11) -C(1) -C(21) 
C(2)-C(3)-C(4) 
C(1) -C(11) ·C(12) 
F-C(14) -C(l3) 
C(1) -C(21) -C(22) 
N-C(32) -C(33) 
109. 7(2) 
109.1(2) 
110. 5(3) 
105. 3(2) 
110.2(2) 
111. 7(2) 
173.2(4) 
118.8(3) 
119.0(3) 
112.8(2) 
111.0(3) 
seleetivity ratio [(R)-2a/(S)-2a] varied, depending on the re-
eeptor subtype studied; it was lowest at M2 reeeptors (ea. 
15). (S)-2a exhibited only weak receptor diseriminatory 
properties, whereas (R)-2a showed a preferenee forMt, M3, 
and M4 over M2 reeeptors (about t6-fold). The affinity pro-
file of (R)-2a (Mt ~ M3 ~ M4 > M2) is very similar to 
that of (R)-hexahydro-difenidol [(R)-1 a] :!c . .lc . .ldl, but different 
from that of rac-p-fluoro-hexahydro-sila-difenidol (rac-2b) 
(M3 ~ M4 ~ Mt > M2)2a·2cl. (R)-2a thus represents a use-
ful tool to further eharaeterize musearinic receptor subtypes. 
As the stereoselectivity ratios [(R)-2a/(S)-2a] dcpend on the 
receptor subtype studied (M1 ~ M3 ~ M4 > M2), these 
ratios ean be used as an additional parameter to identify 
musearlnie reeeptor subtypes providing information that 
racemates cannot give2b.2c.Jb-d>. 
(R)-p-Fluoro-hexahydro-difenidol methiodide [(R)-3a] 
was also found to exhibit higher affinites (by up to two 
orders of magnitude) for M1- M4 receptors than its anti-
pode (S)-3a, and both enantiomers displayed a small pref-
erence for Mt receptors 2c,3d>. However, the stereoseleetivity 
ratios [(R)-3aj(S)-3a] were very similar, regardless of the 
reeeptor subtype studied. 
We thank the Deutsche Forschungsgemeinschaft and the Fonds 
der Chemischen Industrie for financial support. 
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Experimental 
a) Syntheses 
All reactions were performed in dried solvents under a dry ni-
trogen atmosphere unless stated otherwise. - Melting points were 
determined with a Kofler apparatus (Reichert) and are uncor-
rected. - 1H NMR: Bruker AM-400 spectrometer, operating at 
400.1 MHz [CD30D or CDCh as solvents, TMS as internal stan-
dard (o = 0)]. - 13C NMR: Bruker AM-400 spectrometer, oper-
ating at 100.6 MHz [CD30D or CDCI3 as solvents and internal 
standards (CD30D, o = 49.0; CDCh, o = 77.05)]. Assignment of 
the 13C-NMR data was supported by DEPT experiments. -
FAB MS: Finnigan-MAT-8430 spectrometer (glycerol as matrix, 
xenon as FAB source). - Optical rotations: Polarimeter 241, Per-
kin-Eimer. The solvent used for these measurements (CHCh, 
LiChrosoJv®; Merck) was additionally purified prior to use by dy-
namic drying over an Ah03 (Merck) column. 
( R) -1-Cyclohex yl-1- ( 4-fluorophen yl) -4-piperidino-1-butanol H y-
drochloride [ ( R)-p-Fluoro-hexah ydro-difenidol Hydrochloride 1 
[(R)-2a · HCI]: 75 mg of a Pd/C contact (10% Pd; Merck) was 
added to a solution of(R)-4 (2.10 g, 6.37 mmol) in methanol (75 ml). 
The suspension was stirred at room temp. for 2 h under a hydrogen 
atmosphere (continuous H2 flow). The reaction mixture (complete 
conversion, monitored by 1H NMR) was filtered and the filtrate 
concentrated in vacuo. Afteraddition of a 0.5 M solution of HCI in 
ether (12.8 ml, 6.4 mmol HCl) to the oily residue, the solid crude 
product was isolated and purified by two recrystallizations from 2-
propanolfdiethyl ether (2:1, vfv) to give 1.93 g (82%) of colorless 
needles, m.p. 252°C (dec.), [e1]~~6 = -29 (c = 0.5, CHCI3). -
1HNMR (CD30D): o = 0.9-1.3, 1.3-1.6, 1.6-2.1 (m, 21H, 
C6H 11 , OCCH2CH2CH2N, CCH2C of NCsH10); 2.7-2.9, 2.9-3.1, 
3.3-3.5 (m, 6H, CCH2N); 7.0-7.1, 7.35-7.45 {m, 4H, C6H4F). -
13C NMR (CD30D): o = 20.0, 22.7, 24.2 (2C), 27.6, 27.7, 27.8, 
27.9, 28.5 (C-2 to C-6 of C6H 11 , C-3 to C-5 of NC5H 10, 
OCCH2CH2CH2N); 37.0 (OCCH2CH2CH2N); 50.3 (C-1 of C6Htt); 
54.1 (2 C), 58.6 (CCH2N); 79.3 (COH); 115.3 (2C) (d, 2 lcF = 21.3 Hz, 
C-3 and C-5 of C6H4F); 129.1 (2C) (d, 3JcF = 7.7 Hz, C-2 and C-
6 ofC6H4F); 142.0 (d, 4lcF = 3.1 Hz, C-1 ofC6H4F); 162.9 (d, 1lcF = 
243.4 Hz, C-4 of C6H4F). - FAB MS: m/z (%) = 334 (100) 
[cation]. 
C 21H 33CIFNO (369.9) Calcd. C 68.18 H 8.99 N 3.79 
Found C 68.0 H 9.1 N 3.7 
(S )-1-Cyclohexyl-1-( 4-.fluorophenyl)-4-piperidino-1-butanol H y-
drochloride { ( S )-p-Fluoro-hexahydro-difenidol Hydrochloride 1 [(S)-
2a · HCI]: Prepared by catalytic hydrogenation of (S)-4, analo-
gously to the synthesis of(R)-2a · HCI; yield 78%, colorless needles, 
mp. 252°C (dec.), [Cl]~J6 = +29 (c = 0.5, CHCh). For spectro-
scopic data see (R)-2a · HCI. 
C 2tHJJCIFNO (369.9) Calcd. C 68.18 H 8.99 N 3.79 
Found C 68.4 H 9.2 N 3.8 
( R)-1-Cyclohexy/-1-( 4-jluoropheny/)-4-piperidino-1-butano/ 
Methiodide [(R)-3]: Methyliodide (255 mg, 1.8 mmol) was added 
to a solution of (R)-2a (296 mg, 0.89 mmol; obtained from (R)-2a · 
HCl) in acetone (15 ml), and the reaction mixture was stirred at 
30 oc for 3 h. After evaporation of the solvent and the excess of 
methyl iodide, the solid residue was washed with pentane (5 ml) 
and then purified by recrystallization from acetone/diethyl ether to 
give 331 mg (78%) of colorless needles, m.p. 150<>C, [cx]~~6 = -13 
(c = 0.5, CHCI3). - 1H NMR (CD30D): ö = 0.9-1.3.1.35-1.45, 
1.6-1.7, 1.7 -1.85, 1.9-2.1 (m, 21 H, C6H 11 • OCCH2CH2CH2N, 
CCH2C ofNC5H10); 2.94 (s, 3H, NCH3); 3.2-3.3 (m, 6H, CCH2N); 
7.0-7.1, 7.4-7.5 (m, 4H, C6H 4F). - 13C NMR (CD30D): ö = 
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17.8, 20.9 (2C), 22.0, 27.6, 27.8 (2C), 28.0, 28.6 (C-2 to C-6 of C6H11, 
C-3 to C-5 of NC5H10, OCCH2CH 2CH2N); 36.5 (OCCH2CHr 
CH2N); 48.5 (NCH3); 50.4 (C-1 of C6H 11 ); 62.1 (2C) (C-2 and C-6 of 
NC5H 10};, 64.6 (OCCH2CH2CH2N); 79.4 (COH); 115.3 (2C) (d, 
2lcF = 21.0 Hz, C-3 and C-5 of C6H4F); 129.2 (2C) (d, 3JcF = 
7.7 Hz, C-2 and C-6 of C6H4F); 141.9 (d, 4JcF = 3.2 Hz, C-1 of 
C6H4F); 162.9 (d, 1JcF = 243.4 Hz, C-4 of C6H4F). - FAB MS: 
m/z (%) = 348 (100) [cation]. 
C22H35FINO (475.4) Calcd. C 55.58 H 7.42 N 2.95 
Found C 54.8 H 7.7 N 2.9 
( S )-1-Cyclohexyl-1- ( 4-fluorophenyl )-4-piperidino-1-butanol 
Methiodide [(S)-3]: Prepared by quaternization of (S)-2a [obtained 
from (S)-2a · HCI] with methyl iodide, analogously to the synthesis 
of (R)-3; yield 84%, colorless needles, m.p. 150°C, [et]~~6 = +13 
(c = 0.5, CHC13). For spectroscopic data see (R}-3. 
C22H35FINO (475.4) Ca1cd. C 55.58 H 7.42 N 2.95 
Found C 55.2 H 7.6 N 2.9 
rac-1-C yclohex yl-1- ( 4-fluorophen yl) -4-piperidino-2-but yn-1-ol 
[rac-4]: A 1.6 M solution of n-butyllithium in hexane (62.5 ml, 0.1 
mol of n-BuLi) was added dropwise at - 50°C to a stirred solution 
of 3-piperidino-1-propyne (12.3 g, 0.1 mol) in diethyl ether (50 ml). 
After stirring at - 50°C for 2 h, the reaction mixture was added 
dropwise within 30 min at ooc to a stirred solution of cyclohexyl 
(4-fluorophenyl) ketone (20.6 g, 0.1 mol) in diethyl ether (150 ml). 
After stirring for an additional period of 16 h at room temp., water 
(75 ml) was added at ooc to the reaction mixture. The organic layer 
was separated and the aqueous layer extracted with diethyl ether. 
Thereafter, the combined organic extracts were washed with water 
and then dried with anhydrous Na2S04. After evaporation of the 
solvent, the solid residue was purified by recrystallization from 2-
propanol to give 25.0 g (76%) of colorless crystals, m. p. 136 oc 
(subl.). - 1H NMR (CDC13): ö = 1.0-1.1, 1.10-1.25, 1.35 -1.5, 
1.5-1.7, 1.7-1.8, 1.95-2.05 (m, 17H, C6H11 , CCH2C of NC5H10); 
2.45-2.55 (m, 4H, CCH2N of NC5H 10); 3.34 (s, 2H, C:=CCH2N); 
3.7 ("s", 1 H, COH); 6.95-7.05, 7.5-7.6 (m, 4H, C6H4F). -
13C NMR (CDCh): ö = 23.9, 25.6 (2C), 26.19, 26.22, 26.3, 27.7, 27.9 
(C-2 to C-6 of C6H1h C-3 to C-5 of NC5H10); 47.7 (C::CCH2N); 
50.2 (C-1 of C6H 11 ); 53.0 (2C) (C-2 and C-6 of NC5H10); 76.0 (COH); 
81.8, 87.1 (C=C); 114.4 (2C) (d, 2JcF = 21.3 Hz, C-3 and C-5 of 
C6H4F); 128.1 (2C) (d, 3Jn = 7.8 Hz, C-2 and C-6 of C6H4F); 140.2 
(d, 4Jn = 2.1 Hz, C-1 of C6H4F); 162.1 (d. 1./n = 245.6 Hz. C'-4 
of C6 H4F). - FAB MS: mfz (%) = 330 (100) [M + H t]. 
C21 H28FNO (329.5) Calcd. C 76.56 H 8.57 N 4.25 
Found C 76.5 H 8.7 N 4.1 
( R)- and (S )-1-Cyclohexyl-1-( 4-fluorophenyl)-4-piperidino-2-bu-
tyn-1-ol [(R)- and (S)-4]: A mixture of rac-4 (7.4 g, 22.5 mmol) and 
(S)-mandelic acid (3.5 g, 23 mmol) was dissolved in boiling aceto-
nitrile (150 ml). After filtration and cooling of the hot solution to 
room temp., seed crystals (obtained previously by spontaneous crys-
tallization from an analogous reaction mixture, reduced scale) were 
added, and the reaction mixture was kept at 20°C for 24 h (no 
disturbance). The crystals obtained (ca. 4.2 g) were isolated by fil-
tration and then purified by three recrystallizations from acetoni-
trile [after dissolving the crystals (1 g) in hot acetonitrile (30 ml), 
the solution was slowly cooled to room temp.]. Thereafter, a 0.1 M 
aqueous NaOH solution (200 ml) was added to the purified man-
delate (3.3 g), and the liberated amine was isolated by extraction 
with diethyl ether. The ether solution was washed with water and 
then dried with anhydrous Na2S04• After evaporation of the sol-
vent, the solid residue was dried in vacuo and then purified by two 
recrystallizations from acetone to give 2.1 g [57%, related to the 
portion of (R)-4 in rac-4] of (R)-4. (S)-4 was obtained from the 
combined mother Iiquors resulting from the crystallizations of (R)-
4 · C6H5CH(OH)C02H from acetonitrile (see above): After evapo-
ration of the acetonitrile, a 0.1 M aqueous NaOH solution (200 ml) 
and diethyl ether (300 ml) were added to the solid residue. The 
ether layer was separated, washed with water, and dried with an-
hydrous Na2S04• After evaporation of the solvent, the solid residue 
was dried in vacuo and recrystallized from acetone to give 4.5 g of 
colorless crystals, mainly consisting of (S)-4. This product and (R)-
mandelic acid (2.1 g, 13.8 mmol) were dissolved in boiling aceto-
nitrile (ca. 150 ml) and the resulting solutionwas kept at 20°C for 
24 h. The mandelate obtained was isolated by filtration, purified, 
and then transformed into (S)-4 analogously to the preparation of 
(R)-4 as described above; yield 1.85 g [50%, related to the portion 
of (S)-4 in rac-4]. 
(R)-4: Colorless crystals, m.p. 150°C, [cx]~J6 = +14 (c = 0.5, 
CHCh), enantiomeric purity ~99.80% e.e. (see Table 1). For spec-
troscopic data see rac-4. 
C21 H2sFNO (329.5) Calcd. C 76.56 H 8.57 N 4.25 
Found C 76.7 H 8.7 N 4.2 
(S)-4: Colorless crystals, m. p. 150°C, [cx]~J6 = -14 (c = 0.5, 
CHCh), enantiomeric purity ~99.94% e.e. (see Table 1). For spec-
troscopic data see rac-4. 
C21H2sFNO (329.5) Calcd. C 76.56 H 8.57 N 4.25 
Found C 76.4 H 8.5 N 4.3 
( S) -1-C yclohexyl-1- ( 4-.fluorophenyl )-4-piperidino-2-butyn-1-ol 
Methiodide [(S)-5]: Prepared by quaternization of(S)-4 [(- )-4] with 
methyl iodide, analogously to the synthesis of (R)-3; yield 89%, 
colorless needles, m.p. 190°C (dec.), [et]~J6 = -2 (c = 0.5, 
CHCl3).- 'H NMR(CD30D):ö = 1.0-1.3, 1.5-1.8, 1.9-2.0(m, 
17H, C6Hth CCH2C ofNC5H10); 3.24 (s, 3H, NCH3); 3.50-3.65 (m, 
4H, CCH2N of NC5H 10); 4.61 ("s", 2H, C=CCH2N); 7.05-7.15, 
7.50-7.65 (m, 4H, C6H4F). - 13C NMR (CD30D): ö = 21.0 (2C), 
21.9, 27.2 (2C), 27.4, 28.7, 29.0 (C-2 to C-6 of C6H 11, C-3 to C-5 of 
NCsH10); 49.5 (NCH3); 51.3 (C-l of C6H 11); 54.9 (C::CCH2N); 62.0 
(2 C) (C-2 and C-6 of NC5H 10); 76.6 (COH); 74.3, 96.1 (C = C); 115.5 
(2C) (d, 2 JcF = 21.5 Hz, C-3 and C-5 of C6H4F); 129.2 (2C) (d, 3JcF = 8.1 Hz, C-2 and C-6 of C6H4F); 140.6 (d, 4JcF = 3.0 Hz, 
C-1 of C6H4F); 163.6 (d, 1JcF = 244.8 Hz, C-4 of C6H4F). - FAB 
MS: m/z (%) = 344 (100) [cation]. 
C22H3tFINO (471.4) Calcd. C 56.06 H 6.63 N 2.97 
Found C 56.1 H 6.6 N 2.9 
b) Calorimetric Determination of Enantiomeric Purity 
Calorimeter: FP 84 DSC/TOA, Mettier Instruments GmbH, 
GreifenseejSwitzerland (heat-flux DSC). The calibration of the in-
strument, the experimental procedure, and the data evaluation (ex-
cept for the determination of enantiomeric purity) followed the de-
scription in refs. Ml. The results obtained from the calorimetric meas-
urements are listed in Table 1. The uncertainty of the enthalpies 
was ± 2.5%, of the temperatures ± 0.2 K, and of the molar fraction 
of the impurities ±50%. The centrat part of the phase diagram (for 
rac-4 in the range between the two eutectic points) was calculated 
by the PRIGOGINE-DEFAY equation In [4x 1(1 - x1)] = 
2drusH9 /R(1/Trus - 1/1) (see ref. 7~. 
Calorimetric Purity Determination: Simulated DSC curves, based 
on calorimeter parameters, were compared with experimentally ob-
tained DSC curves by variation of the given parameter (in this case 
"impurity concentration") until an optimal fit was obtained. To 
check the enantiomeric purities determined by this method, an ad-
ditional measurement of (S)-4 was performed with a deliberate ad-
dition of 1 mol-% of (R)-4. 
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c) Crystal-Structure Determination 81 
Crystal Data: C22H 31 FINO (471.4); orthorhombic; space group 
P212121; a = 726.2(3), b = 1198.8(4), c = 2548.6(10) pm; V = 
2.219 nm3; Z = 4; Dx = 1.41 Mg m- 3; F(OOO) = 960; /..(Mo Ka) = 
71.069 pm; J.l = 1.4 mm -t. Colorless prism (0.9 x 0.4 x 0.15 mm), 
grown by vapor diffusion of diethyl ether into a solution of (- )-5 
in ethanol. 
Data Collection and Reduction: A hemisphere of data ( ± h 
+k ±1, 8198 reflections, 29max = 50°, monochromatized Mo-Ka 
radiation) were collected in an ro-scan mode with a Siemens P3 
four-circle diffractometer. Three check reflections decreased in in-
tensity by ca. 7%, and an appropriate correction was applied. An 
absorption correction based on \jl scans gave transmission factors 
of 0.72-0.87. Merging equivalent intensities yielded 3918 unique 
reflections (Rint = 0.018), of which 3539 with F > 4cr(F) were used 
for all calculations (program system SHELX, modified by its author 
G. M. Sheldrick). The orientation matrix was refined from setting 
angles of 48 reflections in the range 20 = 20-24°. 
Table 3. Atomic coordinates ( x 104) and equivalent isotropic 
displacement parameters ( x 10- 1) [pm2] for (S)-Sal 
X y z U(eq) 
I 4850.2(3) 1118.6(2) 2524.8(1) 57(1) 
F 1261(4) 3517(2) 4683(1) 93(1) 
0 7512 (3) 4251 (2) 6280(1) 55(1) 
N 4223(4) 6218(2) 7981(1) 42(1) 
C(1) 6332 (4) 5176(3) 6164(1) 43(1) 
C(2) 5392(4) 5560(3) 6649(1) 47(1) 
C(3) 4572(5) 5890(3) 7018(1) 47(1) 
C(4) 3361(4) 6248(3) 7443(1) 51(1) 
C(5) 2694(5) 6450(3) 8360(1) 53(1) 
C(ll) 4921(4) 4727(2) 5775(1) 44(1) 
C(12) 5540(5) 4206(3) 5321(1) 63(1) 
C(l3) 4295(7) 3781(3) 4955(1) 71(1) 
C(l4) 2476(5) 3895(3) 5047(1) 63(1) 
C(15) 1812(5) 4374(4) 5492(2) 73(1) 
C(16) 3069(5} 4789(3) 5854(1) 61(1) 
C(21) 7462(4) 6145(3) 5928(1) 46(1) 
C(22) 8985(5) 6558(3) 6296(1) 56(1) 
C(23) 10143(6) 7440(3) 6031(2) 77 (1) 
C(24) 8984(7) 8410(4) 5842(2) 88(2) 
C(25) 7416(7) 8022(4) 5487(2) 87(2) 
C(26) 6273(5) 7118(3) 5753(1) 62(1) 
C(32) 5705(6) 7095(3) 8018(2) 71(1) 
C(33) 6742(7) 7009(5) 8539(2) 91(2) 
C(34) 7470(6) 5836(5) 8639(2) 97(2) 
C(35) 5987 (6) 4988(4) 8601(2) 75(2) 
C(36) 5020(5) 5069(3) 8078(1) 52(1) 
al U(eq) defined as one third of the trace of the orthogonalized Uii 
tensor. 
Structure Solution and Refinement: The structure was solved by 
direct methods and subjected to full-matrix Ieast-squares refinement 
on F. Hydrogen atoms, all but two of which were located in 
difTerence syntheses, were included in the refinement using a riding 
model. The absolute configuration was determined by an 11 
refinement9l; 11 refined to -1.06(5) for the original model, where-
Liebi~s Ann. Chem. 1991, 523-527 
upon the structure was inverted for the final cycles. The final R 
value was 0.027, with Rw = 0.026. The weighting scheme was 
w- 1 = cr2(F) + 0.00025 · F2• 235 parameters; S = 1.3; max. 
dlcr = 0.03; max. dQ = 0.6 X w-6 e pm-3• Final atomic Coordi-
nates are given in Table 3, selected bond lengths and angles in 
Table 2. 
CAS Registry Numbers 
(R)-2a: 132723-85-4 I (R)-2a · HCI: 132723-86-9 I (S)-2a: 132723-
86-5 I (S)-2a · HCI: 132723-81-0 I(R)-Ja: 132723-82-1 I (S)-3a: 
132723-83-2 I (rac)-4: 127471-25-4 I (R)-4: 127413-19-8 I (S)-4: 
127413-20-1 I (S)-5: 132723-84-3 I 3-piperidino-1-propyne: 5799-
75-7 I cyclohexyl 4-fluorophenyl ketone: 85014-02-4 
tJ Chemistry: laJ Synthesis of rac-1 b: R. Tacke, H. Linoh, H. Zilch, 
J. Wess, U. Moser, E. Mutschler, G. Lambrecht, Liebigs Ann. 
Chem. 1985, 2223. - tbJ rac-2b can be synthesized by analogy 
to rac-1 b; R. Tacke, K. Mahner, C. Strohmann, B. Forth, G. 
Lambrecht, E. Mutschler, unpublished results. 
2l Pharmacology: lal G. Lambrecht, R. Feifel, M. Wagner-Röder, 
C. Strohmann, H. Zilch, R. Tacke, M. Waelbroeck, J. Christophe, 
H. Boddeke, E. Mutschler, Eur. J. Pharmacol. 168 (1989) 71. -
Zbl G. Lambrecht, R. Feifel, U. Moser, M. Wagner-Röder, L. K. 
Choo, J. Camus, M. Tastenoy, M. Waelbroeck, C. Strohmann, 
R. Tacke, J. Rodrigues de Miranda, J. Christophe, E. Mutschler, 
Trends Pharmacol. Sei. (Suppl.) 10 (1989) 60. - lcl M. Wael-
broeck, J. Camus, M. Tastenoy, E. Mutschler, C. Strohmann, R. 
Tacke, G. Lambrecht, J. Christophe, Eur. J. Pharmacol., Mol. 
Pharmacol. Sect., in press. 
3l Jal R. Tacke, C. Strohmann, S. Sarge, H. K. Carnmenga, D. 
Schomburg, E. Mutschler, G. Lambrecht, Liebigs Ann. Chem. 
1988, 137. - Jbl M. Waelbroeck, M. Tastenoy, J. Camus, R. Fei-
fel, E. Mutschler, C. Strohmann, R. Tacke, G. Lambrecht, J. 
Christophe, Trends Pharmacol. Sei. (Suppl.) 10 (1989) 65. -
3c> R. Feifel, M. Wagner-Röder, C. Strohmann, R. Tacke, M. 
Waelbroeck, J. Christophe, E. Mutschler, G. Lambrecht, Br. J. 
Pharmacol. 99 (1990) 455. - 3dl G. Lambrecht, T. P. Friebe, R. 
Feifel, N. Rettenmayr, M. Wagner-Röder, C. Strohmann, R. 
Tacke, E. Mutschler, Arch. Pharm. (Weinheim) 323 (1990) 
790. - 3eJ M. Waelbroeck, J. Camus, M. Tastenoy, E. Mutschler, 
C. Strohmann, R. Tacke, G. Lambrecht, J. Christophe, Chirality, 
in press. 
4l 4al S. Sarge, S. Bauerecker, H. K. Cammenga, Thermochim. Acta 
129 (1988) 309. - 4bl S. Bauerecker, S. Sarge, H. K. Cammenga, 
J. Therm. Anal. 35 (1989) 527. 
5l R. Tacke, H. Linoh, L. Ernst, U. Moser, E. Mutschler, S. Sarge, 
H. K. Cammenga, G. Lambrecht, Chem. Ber. 120 (1987) 1229. 
6l S. Sarge, H. K. Cammenga, Thermochim. Acta 94 (1985) 17. 
7l J. Jacques, A. Collet, S. H. Wilen, Enantiomers, Racemates, and 
Resolutions, pp. 88-90, John Wiley & Sons, New York 1981. 
8l Further details of the structure investigation (complete bond 
lengths and angles, torsion angles, hydrogen atom coordinates, 
structure factors, temperature factors) are available on request 
from the Fachinformationszentrum Karlsruhe, Gesellschaft für 
wissenschaftlich-technische Information mbH, D-7 514 Eggen-
stein-Leopoldshafen 2, Federal Republic of Germany, on quot-
ing the depository number CSD-55047, the names ofthe authors, 
and the journal citation. 
9l D. Rogers, Acta Crystallogr., Sect. A, 37 (1981) 734. 
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